Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 104373-85-5 | MDL No. : | MFCD01702072 |
Formula : | C12H17N3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XQYZTEXKRYMSQG-UHFFFAOYSA-N |
M.W : | 235.28 | Pubchem ID : | 6485183 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 71.88 |
TPSA : | 56.67 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.86 cm/s |
Log Po/w (iLOGP) : | 1.79 |
Log Po/w (XLOGP3) : | -1.58 |
Log Po/w (WLOGP) : | -0.08 |
Log Po/w (MLOGP) : | 0.58 |
Log Po/w (SILICOS-IT) : | 0.57 |
Consensus Log Po/w : | 0.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.3 |
Solubility : | 118.0 mg/ml ; 0.501 mol/l |
Class : | Very soluble |
Log S (Ali) : | 0.9 |
Solubility : | 1860.0 mg/ml ; 7.91 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -2.0 |
Solubility : | 2.37 mg/ml ; 0.0101 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.08 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | In benzene Heating; |
A258166[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Reason: Free-salt
[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Similarity: 0.98
[ 1185293-81-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid hydrochloride
Similarity: 0.98
[ 883544-42-1 ]
2-Methyl-3-(4-(pyridin-2-yl)piperazin-1-yl)propanoic acid
Similarity: 0.93
[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Similarity: 0.98
[ 1185293-81-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid hydrochloride
Similarity: 0.98
[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Similarity: 0.98
[ 1185293-81-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid hydrochloride
Similarity: 0.98
[ 883544-42-1 ]
2-Methyl-3-(4-(pyridin-2-yl)piperazin-1-yl)propanoic acid
Similarity: 0.93
[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Similarity: 0.98
[ 1185293-81-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid hydrochloride
Similarity: 0.98
[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Similarity: 0.98
[ 1185293-81-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid hydrochloride
Similarity: 0.98
[ 883544-42-1 ]
2-Methyl-3-(4-(pyridin-2-yl)piperazin-1-yl)propanoic acid
Similarity: 0.93
[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Similarity: 0.98
[ 1185293-81-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid hydrochloride
Similarity: 0.98